{
    "code": "01046241",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01046241",
    "time": "2018-08-31 03:45:32",
    "許可證字號": "衛署藥製字第046241號",
    "註銷狀態": "已註銷",
    "註銷日期": "106\/06\/15",
    "註銷理由": "自請註銷",
    "有效日期": "107\/07\/28",
    "發證日期": "93\/05\/14",
    "許可證種類": "製　劑",
    "舊證字號": "00000000",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00104624109",
    "中文品名": "癲舒液",
    "英文品名": "CARBATOL  20MG\/ML MIXTURE",
    "適應症": "癲癇症(Epilepsy)、三叉神經痛(Trigerminal neuragia)、腎原性尿崩症 (Diabetes insipidus, nephrogenic)、雙極性疾患(Bipolar disorder)。",
    "劑型": "170內服液劑",
    "包裝": "4000公撮以下瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "CARBAMAZEPINE"
    ],
    "限制項目": "1D須執行風險管理計畫",
    "申請商名稱": "620110H937  歐強國際有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "0402602300  中國化學製藥股份有限公司新豐工廠",
        "製造廠廠址": "新竹縣新豐鄉坑子口１８２之１號",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2812000400",
            "成分名稱": "CARBAMAZEPINE",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "MG"
        }
    ]
}